StockNow
Log in
U.S. Markets

Eli Lilly (LLY) acquires Merida Biosciences for up to USD 2.875bln to advance treatments for serious autoimmune and allergic diseases

StockNow breaking-news AI analysis

Eli Lilly acquires Merida Biosciences for up to USD 2.875 billion to advance treatments for serious autoimmune and allergic diseases.

1 stocks
LLYEli Lilly & Co.$1,171.47Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

[MARKET UPDATE] Modest downside in Energy benchmarks as newswires re-run comments from Iranian President Pezeshkian, supporting equities and weighing on the USD

Commodities

[MARKET UPDATE] Dutch TTF front-month contract has risen above EUR 70/MWh, reaching levels last seen in March. Further pressure seen in Bunds amidst this.

Global Markets

Samsung Electronics (005930 KS) memory unit has allocated c. 70% of production capacity to be supplied by 2031 as LTA, SE Daily reports citing sources; main partners are Nvidia (NVDA), Alphabet (GOOGL) and Microsoft (MSFT)

005930NVDAGOOGL